Crescent Capital BDC (CCAP) Earnings Analysis

Crescent Capital BDC (CCAP) next reports earnings on 2026-08-12, consensus EPS 0.37 USD. Last quarter (2026-02-25) it beat with EPS 0.45 USD vs 0.44 USD est (+2.3%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E 26.98.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CCAP next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate0.37 USD
Revenue estimate0.04B

CCAP earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-250.45 USD0.44 USD+2.3%Beat
2025-08-130.46 USD0.46 USD0%Beat
2025-02-190.55 USD0.56 USD-1.8%Miss
2024-08-120.59 USD0.58 USD+1.7%Beat

Beat rate: 3/4 (75%) over reported quarters with consensus data.

CCAP valuation and analyst view

Trailing P/E26.98
Trailing EPS0.40874 USD
Price / book0.61
Dividend yield15.19%
Market cap0.41B
Analyst consensusBuy (4 buy / 2 hold / 0 sell)
Avg price target14 USD

Related research pages

Frequently asked questions

When is Crescent Capital BDC (CCAP)'s next earnings date?

Crescent Capital BDC is next scheduled to report on 2026-08-12, with a consensus EPS estimate of 0.37 USD and revenue estimate of 0.04B.

Did CCAP beat earnings last quarter?

In its 2026-02-25 report, CCAP posted EPS of 0.45 USD versus a 0.44 USD estimate — a beat of 2.3%.

What is CCAP's earnings track record?

Over the last 4 reported quarters with consensus data, CCAP beat estimates 3 times (75%).

What is CCAP's current P/E ratio and EPS?

CCAP trades at a trailing P/E of 26.98 on trailing EPS of 0.40873910864107843 USD.

What do analysts rate CCAP?

Analyst consensus is "Buy" across 6 ratings (0 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 14 USD.